You just read:

Arena Pharmaceuticals Completes Enrollment in Ralinepag Phase 2 Clinical Trial for Pulmonary Arterial Hypertension (PAH)

News provided by

Arena Pharmaceuticals, Inc.

Dec 07, 2016, 08:30 ET